The Impact of Antiviral Therapy for Hepatitis C Virus on the Survival of Patients after Hepatocellular Carcinoma Treatment

OBJECTIVE: Owing to advances in direct-acting antiviral (DAA) therapy, a considerable number of patients with hepatitis C virus (HCV)-positive hepatocellular carcinoma (HCC) are now able to achieve a sustained viral response (SVR) after curative treatment of HCC. However, the beneficial effect of a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mori, Yuki, Matsuda, Shuya, Sato, Mitsuaki, Muraoka, Masaru, Suzuki, Yuichiro, Tatsumi, Akihisa, Nakayama, Yasuhiro, Inoue, Taisuke, Maekawa, Shinya, Enomoto, Nobuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556239/
https://www.ncbi.nlm.nih.gov/pubmed/36104175
http://dx.doi.org/10.2169/internalmedicine.8456-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556239/
https://www.ncbi.nlm.nih.gov/pubmed/36104175
http://dx.doi.org/10.2169/internalmedicine.8456-21

Ejemplares similares